Form 4: EHC CFO's Stock Transactions: Tax Withholding & Option Grant

Encompass Health's EVP & CFO, Douglas E. Coltharp, reported the disposition of shares for tax obligations and the acquisition of non-qualified stock options.

Summary

• Douglas E. Coltharp, Executive Vice President and Chief Financial Officer of Encompass Health Corp (EHC), reported changes in his beneficial ownership.
• On February 28, 2026, 776 shares of Encompass Health Common Stock were disposed of at a price of $107.88 per share. These shares were withheld or surrendered to cover tax withholding obligations related to the vesting of restricted stock.
• Following this transaction, Mr. Coltharp directly beneficially owns 69,377 shares of common stock.
• Indirect beneficial ownership includes 27,480 shares via an irrevocable trust, 125,631 shares via an irrevocable trust for the benefit of children, and 37,749 shares by his spouse.
• On March 2, 2026, Mr. Coltharp acquired 12,275 non-qualified stock options with an exercise price of $108.06 per share.
• These options become exercisable in equal annual installments over a three-year period, commencing March 2, 2027, and have an expiration date of March 2, 2036.
• Following this acquisition, Mr. Coltharp directly beneficially owns 12,275 derivative securities (non-qualified stock options).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as slightly positive. While there was a disposition of shares, it was for routine tax purposes. The acquisition of new stock options for the CFO is a positive signal, aligning management's long-term interests with shareholder value.

Positives

• The acquisition of 12,275 non-qualified stock options aligns the Executive Vice President and Chief Financial Officer's interests with long-term shareholder value, as the options vest over a three-year period and have a ten-year expiration date.

Negatives

• The disposition of 776 shares of common stock, valued at $107.88 per share, reduced direct beneficial ownership, although this was for tax withholding obligations related to restricted stock vesting.

Future Outlook

The acquired non-qualified stock options will become exercisable in equal annual installments over a three-year period, commencing March 2, 2027, indicating a future incentive structure for the EVP & CFO.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, detailing changes in their beneficial ownership of company securities. These transactions, involving tax-related dispositions and option grants, are common components of executive compensation packages and do not typically signal a significant shift in company strategy or performance.

Stakeholder Impact

• Shareholders: The grant of stock options to the CFO aligns executive incentives with shareholder interests, potentially encouraging long-term value creation. The tax-related disposition is a routine event with minimal direct impact on other shareholders.

Next Steps

• The non-qualified stock options will begin to vest in equal annual installments starting March 2, 2027, over a three-year period.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (tax withholding and option grants). It does not provide new fundamental information about Encompass Health's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not present a compelling reason to buy or sell based solely on these disclosures.

Keywords

Encompass Health, EHC, Form 4, Insider Transaction, Stock Options, Beneficial Ownership, CFO, Tax Withholding